bioRxivBioengineeringPreprint
pH-responsive nano-vaccines as antigen and adjuvant carrier that improve vaccine immunogenicity
Abstract
Here, we report a novel method to establish an effective antigen and immunoagonist co-vector to solve the problems of low antigenic endocytosis efficiency, low immunological activity and easy degradation of antigen by antigen presenting cells. Mesoporous silica was selected as the nucleus. After loading the model antigen chicken egg albumin (OVA), the metal organic framework (MOF) formed by Eu 3+ and guanine mononucleotide (GMP) was coated on the mesoporous silicon surface. The immunostimulant CpG nucleic acid is adsorbed on the surface to construct a co-carrier system of pH-sensitive antigen and immunostimulant. The antigen loading rate of mesoporous silicon was 20%, and the protein release amount reached 55% after incubation for 24 h under acidic conditions. Transmission electron microscopy showed that the conjugated polymer was uniformly coated on the surface of the material; It was found that the adsorption capacity of the carrier for CpG nucleic acid was 8 x10-6 mol per gram of carrier-adsorbing nucleic acid; MTT results showed that the vector had low toxicity.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tunable Rigid Spikes on Virus-Like Porous Silica Enable Mechanistically Controlled Nanovaccine Platforms
Cui Pang, Jiajia Wang, … Wujun Xu·Journal of Controlled ReleasePeer-reviewed·Jul 4, 2026
- MAGE-3 peptide amphiphile micelle vaccine promote anti-tumor immunity in mice with stomach cancer.
J. Windberg, R. Zhang·bioRxiv·Apr 16, 2019
- A modified porous silicon microparticle promotes mucosal delivery of SARS-CoV-2 antigen and induction of potent and durable systemic and mucosal T helper 1 skewed protective immunity
- Nanoparticle-Conjugated TLR9 Agonists Improve the Potency, Durability, and Breadth of COVID-19 Vaccines
B. S. Ou, J. Baillet, … E. Appel·bioRxiv·Jan 2, 2023
- Shaping neonatal immunization by tuning delivery of synergistic adjuvants via nanocarriers
S. Barman, F. Borriello, … D. J. Dowling·bioRxiv·Jun 3, 2022
- A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.
D. P. Mayer, M. Nelson, … J. S. Weinstein·bioRxiv·Jan 30, 2024